Publication | Closed Access

Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay

Complementary TestOncologyAllergyMedicineImmunologyNasopharyngeal CancerPathologyEbna 1Serologic TestingNasopharyngeal CarcinomaMolecular DiagnosticsCancer ResearchCancer-associated Virus